Back
Jaguar Health Vs. Perspective Therapeutics Industry Stock Comparison
Sell
17
JAGX
Jaguar Health
Last Price:
1.08
Seasonality Move:
-38.2%
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.26
Seasonality Move:
-10.19%
Sell
17
Jaguar Health (JAGX)
is a Sell
Is Jaguar Health a Buy, Sell or Hold?
- The current Jaguar Health [JAGX] share price is $1.07. The Score for JAGX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- JAGX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.23. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JAGX Stock Price Chart
What is Jaguar Health's stock price today?
-
The Jaguar Health share price today is $1.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JAGX is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
JAGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 34.38 | Sell |
Chaikin Money Flow: | -216609 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.09 - 1.19) | Sell |
Bollinger Bands (100): | (-0.49 - 9.87) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 41.35 | Sell |
Chaikin Money Flow: | -3362413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.88 - 15.76) | Sell |
Bollinger Bands (100): | (11.5 - 15.9) | Sell |
JAGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.11 | Sell |
20-day SMA: | 1.12 | Sell |
50-day SMA: | 1.59 | Sell |
200-day SMA: | 5.89 | Sell |
8-day EMA: | 1.11 | Sell |
20-day EMA: | 1.17 | Sell |
50-day EMA: | 1.91 | Sell |
200-day EMA: | 36.26 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.14 | Sell |
20-day SMA: | 14.89 | Sell |
50-day SMA: | 13.76 | Sell |
200-day SMA: | 11.32 | Buy |
8-day EMA: | 13.91 | Sell |
20-day EMA: | 14.32 | Sell |
50-day EMA: | 13.92 | Sell |
200-day EMA: | 11.52 | Buy |
Jaguar Health Earnings Growth & JAGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $71.43 per share, an increase next quarter of $1.81 per share, an increase this year of $0.43 per share, and an increase next year of $2.79 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
Jaguar Health Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |